Published in Life Sci on October 25, 2002
4,4'-Dichloro-2,2'-[(3aR,7aR/3aS,7aS)-2,3,3a,4,5,6,7,7a-octa-hydro-1H-1,3-benzimidazole-1,3-di-yl)bis-(methyl-ene)]diphenol. Acta Crystallogr Sect E Struct Rep Online (2010) 6.06
2,2'-[(3aRS,7aRS)-Perhydro-benz-imid-azole-1,3-di-yl)bis-(methyl-ene)]diphenol. Acta Crystallogr Sect E Struct Rep Online (2010) 5.05
4,4'-Dichloro-2,2'-[imidazolidine-1,3-diylbis(methylene)]diphenol. Acta Crystallogr Sect E Struct Rep Online (2011) 4.30
2,2'-[Imidazolidine-1,3-diylbis(methyl-ene)]diphenol. Acta Crystallogr Sect E Struct Rep Online (2011) 2.88
1,3-Bis[(1H-benzotriazol-1-yl)meth-yl]-2,3-dihydro-1H-benzimidazole. Acta Crystallogr Sect E Struct Rep Online (2011) 2.53
4,4'-Difluoro-2,2'-{[(3aRS,7aRS)-2,3,3a,4,5,6,7,7a-octa-hydro-1H-1,3-benzimidazole-1,3-di-yl]bis-(methyl-ene)]}diphenol. Acta Crystallogr Sect E Struct Rep Online (2011) 2.18
3,3'-Ethyl-enebis(3,4-dihydro-6-chloro-2H-1,3-benzoxazine). Acta Crystallogr Sect E Struct Rep Online (2010) 2.18
2,9-Dimethyl-6H,13H-5:12,7:14-dimethano-dibenzo[d,i][1,3,6,8]tetraazecine. Acta Crystallogr Sect E Struct Rep Online (2009) 1.97
4,4'-Dibromo-2,2'-{[(3aS,7aS)-2,3,3a,4,5,6,7,7a-octa-hydro-1H-1,3-benzimidazole-1,3-di-yl]bis-(methyl-idene)}diphenol. Acta Crystallogr Sect E Struct Rep Online (2011) 1.93
3,3'-(Ethane-1,2-di-yl)bis-(6-methyl-3,4-dihydro-2H-1,3-benzoxazine). Acta Crystallogr Sect E Struct Rep Online (2011) 1.78
1-Heptyl-1,3,6,8-tetraaza-tricyclo-[4.3.1.1]undecan-1-ium iodide. Acta Crystallogr Sect E Struct Rep Online (2011) 1.67
6,6'-Di-tert-butyl-4,4'-dimeth-oxy-2,2'-[1,3-diazinane-1,3-diylbis(methyl-ene)]diphenol 0.19-hydrate. Acta Crystallogr Sect E Struct Rep Online (2011) 1.55
3,3'-(Ethane-1,2-di-yl)bis-(3,4-dihydro-2H-1,3-benzoxazine). Acta Crystallogr Sect E Struct Rep Online (2011) 1.33
Di-n-propyl 4,4'-dihy-droxy-3,3'-{[(3aRS,7aRS)-2,3,3a,4,5,6,7,7a-octa-hydro-1H-benzimidazole-1,3-di-yl]bis-(methyl-ene)}dibenzoate. Acta Crystallogr Sect E Struct Rep Online (2011) 1.23
Di-n-butyl 4,4'-dihy-droxy-3,3'-{[(3aRS,7aRS)-2,3,3a,4,5,6,7,7a-octa-hydro-1H-1,3-benzimidazole-1,3-di-yl]bis-(methyl-ene)}dibenzoate. Acta Crystallogr Sect E Struct Rep Online (2011) 1.23
Safety, tolerability and immunogenicity of new formulations of the Plasmodium falciparum malaria peptide vaccine SPf66 combined with the immunological adjuvant QS-21. Vaccine (2002) 1.16
T cell recognition and therapeutic effect of a phosphorylated synthetic peptide of the 70K snRNP protein administered in MR/lpr mice. Eur J Immunol (2003) 1.14
2,9-Dichloro-6H,13H-5:12,7:14-di-methano-dibenzo[d,i][1,3,6,8]tetra-azecine. Acta Crystallogr Sect E Struct Rep Online (2011) 1.07
4,4'-Dimeth-oxy-2,2'-{[(3aRS,7aRS)-2,3,3a,4,5,6,7,7a-octa-hydro-1H-1,3-benzimidazole-1,3-diyl]bis(methyl-ene)}diphenol. Acta Crystallogr Sect E Struct Rep Online (2011) 1.04
1,1'-[(2,3,3a,4,5,6,7,7a-Octa-hydro-1H-1,3-benzimidazole-1,3-di-yl)bis-(methyl-ene)]bis-(1H-benzotriazole). Acta Crystallogr Sect E Struct Rep Online (2011) 0.97
Diethyl 4,4'-dihy-droxy-3,3'-{[(3aRS,7aRS)-2,3,3a,4,5,6,7,7a-octa-hydro-1H-1,3-benzimidazole-1,3-di-yl]bis-(methyl-ene)}dibenzoate. Acta Crystallogr Sect E Struct Rep Online (2011) 0.97
Plasmodium vivax merozoite surface protein 8 cloning, expression, and characterisation. Biochem Biophys Res Commun (2004) 0.94
Analysis of a delayed epidemic model with pulse vaccination and saturation incidence. Vaccine (2006) 0.94
3,3'-(Ethane-1,2-diyl)bis(6-meth-oxy-3,4-dihydro-2H-1,3-benzoxazine) mono-hydrate. Acta Crystallogr Sect E Struct Rep Online (2012) 0.93
Molecular modeling and in silico characterization of Mycobacterium tuberculosis TlyA: possible misannotation of this tubercle bacilli-hemolysin. BMC Struct Biol (2011) 0.92
Anti-group A streptococcal vaccine epitope: structure, stability, and its ability to interact with HLA class II molecules. J Biol Chem (2010) 0.92
4,4'-Dibromo-2,2'-{ethane-1,2-diylbis[(methyl-imino)-methyl-ene]}diphenol. Acta Crystallogr Sect E Struct Rep Online (2011) 0.92
Identifying Plasmodium falciparum merozoite surface antigen 3 (MSP3) protein peptides that bind specifically to erythrocytes and inhibit merozoite invasion. Protein Sci (2005) 0.92
1-Hexyl-1,3,6,8-tetra-aza-tricyclo-[4.3.1.1]undecan-1-ium iodide. Acta Crystallogr Sect E Struct Rep Online (2011) 0.92
Computational prediction and experimental assessment of secreted/surface proteins from Mycobacterium tuberculosis H37Rv. PLoS Comput Biol (2010) 0.91
Identification of conserved erythrocyte binding regions in members of the Plasmodium falciparum Cys6 lipid raft-associated protein family. Vaccine (2009) 0.91
Frequency of human papillomavirus infection, coinfection, and association with different risk factors in Colombia. Ann Epidemiol (2011) 0.90
(1H-Benzimidazol-1-yl)methanol. Acta Crystallogr Sect E Struct Rep Online (2012) 0.90
Enhancing immunogenicity and reducing dose of microparticulated synthetic vaccines: single intradermal administration. Pharm Res (2004) 0.89
Gender-based violence and mental disorders in female college students. Soc Psychiatry Psychiatr Epidemiol (2012) 0.89
Major histocompatibility complex and T cell interactions of a universal T cell epitope from Plasmodium falciparum circumsporozoite protein. J Biol Chem (2006) 0.88
Specific erythrocyte binding capacity and biological activity of Plasmodium falciparum erythrocyte binding ligand 1 (EBL-1)-derived peptides. Protein Sci (2005) 0.88
New lanostanoids from the fungus Ganoderma concinna. J Nat Prod (2002) 0.88
Plasmodium falciparum TryThrA antigen synthetic peptides block in vitro merozoite invasion to erythrocytes. Biochem Biophys Res Commun (2005) 0.87
Identification of three gp350/220 regions involved in Epstein-Barr virus invasion of host cells. J Biol Chem (2005) 0.87
Reference strand conformational analysis (RSCA) is a valuable tool in identifying MHC-DRB sequences in three species of Aotus monkeys. Immunogenetics (2006) 0.86
Identification and characterisation of the Plasmodium vivax rhoptry-associated protein 2. Biochem Biophys Res Commun (2005) 0.86
Antigenicity of Leishmania braziliensis histone H1 during cutaneous leishmaniasis: localization of antigenic determinants. Clin Diagn Lab Immunol (2002) 0.85
Sporozoite and liver stage antigen Plasmodium falciparum peptides bind specifically to human hepatocytes. Vaccine (2004) 0.85
Validating subcellular localization prediction tools with mycobacterial proteins. BMC Bioinformatics (2009) 0.84
Comparison of relaxation training with a cognitive-behavioural intervention for indicated prevention of depression in university students: a randomized controlled trial. J Psychiatr Res (2012) 0.84
Classical molecular tests using urine samples as a potential screening tool for human papillomavirus detection in human immunodeficiency virus-infected women. J Clin Microbiol (2013) 0.84
Antigenic properties of the Leishmania infantum GRP94 and mapping of linear B-cell epitopes. Immunol Lett (2002) 0.84
MAEBL Plasmodium falciparum protein peptides bind specifically to erythrocytes and inhibit in vitro merozoite invasion. Biochem Biophys Res Commun (2004) 0.84
The diagnostic performance of classical molecular tests used for detecting human papillomavirus. J Virol Methods (2012) 0.84
Owl monkey MHC-DRB exon 2 reveals high similarity with several HLA-DRB lineages. Immunogenetics (2006) 0.84
Identifying gp85-regions involved in Epstein-Barr virus binding to B-lymphocytes. Biochem Biophys Res Commun (2004) 0.84
Identifying and characterising the Plasmodium falciparum merozoite surface protein 10 Plasmodium vivax homologue. Biochem Biophys Res Commun (2005) 0.83
Identification and polymorphism of Plasmodium vivax RBP-1 peptides which bind specifically to reticulocytes. Peptides (2002) 0.83
Identification of the Plasmodium falciparum rhoptry neck protein 5 (PfRON5). Gene (2010) 0.83
Mycobacterium tuberculosis Rv0679c protein sequences involved in host-cell infection: potential TB vaccine candidate antigen. BMC Microbiol (2010) 0.83
Peptides from the Plasmodium falciparum STEVOR putative protein bind with high affinity to normal human red blood cells. Peptides (2005) 0.83
Identifying Plasmodium falciparum cytoadherence-linked asexual protein 3 (CLAG 3) sequences that specifically bind to C32 cells and erythrocytes. Protein Sci (2005) 0.83
Studies of Plasmodium falciparum rhoptry-associated membrane antigen (RAMA) protein peptides specifically binding to human RBC. Vaccine (2007) 0.83
Cutaneous tuberculosis diagnosis in an inhospitable Amazonian region by means of telemedicine and molecular biology. J Am Acad Dermatol (2005) 0.82
Enhancing immunogenicity to PLGA microparticulate systems by incorporation of alginate and RGD-modified alginate. Eur J Pharm Sci (2011) 0.82
Role of the subcommissural organ in the pathogenesis of congenital hydrocephalus in the HTx rat. Cell Tissue Res (2013) 0.82
Identification of specific Hep G2 cell binding regions in Plasmodium falciparum sporozoite-threonine-asparagine-rich protein (STARP). Vaccine (2003) 0.81
Allele effects in MHC-peptide interactions: a theoretical analysis of HLA-DRbeta1*0101-HA and HLA-DRbeta1*0401-HA complexes. Biochem Biophys Res Commun (2005) 0.81
A new approach to obtaining Nα -t-Boc-amino acid aldehydes from asparagine and glutamine for reduced amide pseudopeptide solid-phase synthesis. Chem Biol Drug Des (2011) 0.81
Human papillomavirus detection from human immunodeficiency virus-infected Colombian women's paired urine and cervical samples. PLoS One (2013) 0.81
Developmental biology of sporozoite-host interactions in Plasmodium falciparum malaria: implications for vaccine design. Clin Microbiol Rev (2006) 0.81
Midpoints for fuzzy sets and their application in medicine. Artif Intell Med (2003) 0.81
NClassG+: A classifier for non-classically secreted Gram-positive bacterial proteins. BMC Bioinformatics (2011) 0.81
Protection against experimental malaria associated with AMA-1 peptide analogue structures. FEBS Lett (2002) 0.81
Lanostanoid triterpenes from Laetiporus sulphureus and apoptosis induction on HL-60 human myeloid leukemia cells. J Nat Prod (2004) 0.81
A theoretical analysis of HLA-DRbeta1*0301-CLIP complex using the first three multipolar moments of the electrostatic field. Biochimie (2006) 0.80
Characterising Mycobacterium tuberculosis Rv1510c protein and determining its sequences that specifically bind to two target cell lines. Biochem Biophys Res Commun (2005) 0.80
Identifying putative Mycobacterium tuberculosis Rv2004c protein sequences that bind specifically to U937 macrophages and A549 epithelial cells. Protein Sci (2005) 0.80
Nucleic-acid-binding properties of the C2-L1Tc nucleic acid chaperone encoded by L1Tc retrotransposon. Biochem J (2009) 0.80
Determining the 3D structure of human ASC2 protein involved in apoptosis and inflammation. Biochem Biophys Res Commun (2005) 0.80
The GPI-anchored 6-Cys protein Pv12 is present in detergent-resistant microdomains of Plasmodium vivax blood stage schizonts. Protist (2012) 0.80
Peptides of the liver stage antigen-1 (LSA-1) of Plasmodium falciparum bind to human hepatocytes. Peptides (2003) 0.80
Conserved high activity binding peptides from the Plasmodium falciparum Pf34 rhoptry protein inhibit merozoites in vitro invasion of red blood cells. Peptides (2010) 0.80
Two L1-peptides are excellent tools for serological detection of HPV-associated cervical carcinoma lesions. Biochem Biophys Res Commun (2005) 0.80
Functional characterization of Mycobacterium tuberculosis Rv2969c membrane protein. Biochem Biophys Res Commun (2008) 0.79
Plasmodium falciparum: red blood cell binding studies using peptides derived from rhoptry-associated protein 2 (RAP2). Biochimie (2004) 0.79
Persistence, clearance and reinfection regarding six high risk human papillomavirus types in Colombian women: a follow-up study. BMC Infect Dis (2014) 0.79
BTM-P1 polycationic peptide biological activity and 3D-dimensional structure. Biochem Biophys Res Commun (2006) 0.79
Amino terminal peptides from the Plasmodium falciparum EBA-181/JESEBL protein bind specifically to erythrocytes and inhibit in vitro merozoite invasion. Biochimie (2005) 0.79
Identification, cloning, and sequencing of different cytokine genes in four species of owl monkey. Immunogenetics (2002) 0.79
Isolation, structure elucidation, total synthesis, and evaluation of new natural and synthetic ceramides on human SK-MEL-1 melanoma cells. J Med Chem (2006) 0.79
Modified merozoite surface protein-1 peptides with short alpha helical regions are associated with inducing protection against malaria. Eur J Biochem (2003) 0.79
Human papillomavirus type 16 and 18 L1 protein peptide binding to VERO and HeLa cells inhibits their VLPs binding. Int J Cancer (2003) 0.78
Conserved regions of the Plasmodium falciparum rhoptry-associated protein 3 mediate specific host-pathogen interactions during invasion of red blood cells. Peptides (2010) 0.78
Mycobacterium tuberculosis Rv2536 protein implicated in specific binding to human cell lines. Protein Sci (2005) 0.78
The T-cell receptor in primates: identifying and sequencing new owl monkey TRBV gene sub-groups. Immunogenetics (2005) 0.78
MHC allele-specific binding of a malaria peptide makes it become promiscuous on fitting a glycine residue into pocket 6. Biochem Biophys Res Commun (2003) 0.78
Plasmodium falciparum merozoite surface protein 6 (MSP-6) derived peptides bind erythrocytes and partially inhibit parasite invasion. Peptides (2006) 0.78
P. falciparum: merozoite surface protein-8 peptides bind specifically to human erythrocytes. Peptides (2003) 0.78
Monosaccharides modulate HCV E2 protein-derived peptide biological properties. Biochem Biophys Res Commun (2007) 0.78